The IntelliNews Romanian Pharmaceutical Report offers an extensive summary of the Romanian pharmaceuticals market, segmented into production and distribution. It includes a complete coverage of the latest developments, trends and corporate news, accompanied by thorough statistics and comments. This sector report is ideal to keep you abreast on recent company and industry news. Written by local professionals, it is a unique market and business intelligence analysis, tailored to save time by providing in-depth information, while helping you to make confident and informed business decisions.
In Q4 alone pharmaceutical sales advanced by 28.2% y/y (29.6% y/y in RON terms), to EUR 694.8mn (RON 3bn), as effect of low base, seasonality and increasing parallel exports, which have become more sophisticated, including at pharmacies' level. Market players' expectations remain optimistic for this year, mainly on the back of the expected new health bill that will involve more actively the private sector. The endogenous demand-side factors, like the low per-capita consumption of medicines, will predictably remain the main driver for growth in 2012. But the the growth outlook remains volatile as a result of the unpredictable exogenous impact of the authorities' decisions. market research report
Reforming the healthcare system is part of the government's precautionary agreement with the IMF, EU and the World Bank, yet the authorities' moves are difficult to predict given public sensitivity against the bill. The controversial stipulations of a first version of the bill stirred public protests earlier in January, in the context of parliamentary elections scheduled for the autumn.
The private healthcare services advanced by 15% y/y to around EUR 520mn in 2011. Major players announced plans to continue expansion this year and this is not surprising, since the subfinancing and poor services in the public system keep fueling the demand for private services. Nonetheless, the sector's performance in 2012 is linked to the evolution of the entire business environment, which will impact on companies' and consumers' revenues.
Table of Contents Executive summary 3 Market overview 4 Pharma market advances 115% y/y to EUR 25bn in 2011 4 Prospects for 2012 remains optimistic, but market is still volatile 4 Government to set new healthcare bill by yearend, after controversal failed attempt 6 Private healthcare market advances 15% y/y to EUR 520mn in 2011 6 Top healthcare providers to continue investments this year, 16 new hospitals expected 7 Sanofi-Aventis maintains leading position in pharmaceutical companies ranking in 2011 8 Drug producers 9 Drug producers maintain focus on exports, to compensate liquidity problems on local market 9 Roche Romania projects cautious 5% y/y increase of sales in 2012 9 Drug maker Zentiva reports 45% y/y profit drop to RON 316mn in 2011 10 GSK Romania plans to continue investments this year 10 Drug producer Antibiotice reports 60% y/y profit increase in 2011, to RON 20mn 10